Celecoxib alleviates the DSS-induced ulcerative colitis in mice by enhancing intestinal barrier function, inhibiting ferroptosis and suppressing apoptosis.
Yaxian LiMengdi MaXiaodong WangJing LiZiqing FangJianhui LiBo YangYida LuXin XuYongxiang LiPublished in: Immunopharmacology and immunotoxicology (2024)
Our findings suggest that celecoxib effectively treats DSS-induced UC in mice by inhibiting ferroptosis and apoptosis.